Microdosing GLP-1 for Weight Maintenance: Does It Actually Work?
Matt · May 25, 2026
Microdosing GLP-1 medications means using doses below the typical weight-loss range — often a fraction of what people take during active fat loss — to help maintain results, blunt appetite, or reduce side effects. Many users report that small weekly doses are enough to keep weight stable after hitting their goal, but research on long-term microdosing is still limited and protocols vary widely.
What microdosing actually looks like in practice
The FDA-approved weight loss dose for semaglutide (Wegovy) tops out at 2.4 mg weekly. Tirzepatide (Zepbound) goes up to 15 mg. Microdosing typically means dropping well below those targets — sometimes 0.25 mg semaglutide weekly, or 2.5 mg tirzepatide every other week, instead of titrating up to maintenance levels.
Why people try it:
- Maintaining weight loss after reaching their goal weight
- Reducing side effects like nausea, fatigue, or constipation
- Stretching expensive prescriptions or compounded supply
- Avoiding the "rebound" that often follows stopping GLP-1s entirely
There's no official microdosing protocol. Some users split their pen into smaller weekly doses, others stretch out their dosing schedule from weekly to every 10-14 days. Both approaches need careful tracking to know what's actually working.
Does the research support it?
Honestly, not much yet. The STEP and SURMOUNT trials studied therapeutic doses, not microdosing. What we do know:
- Most patients regain a significant portion of lost weight within a year of stopping GLP-1s entirely
- Lower doses still produce measurable appetite suppression in many people
- Side effects scale roughly with dose, so smaller amounts mean fewer GI issues for most users
- Some endocrinologists have started prescribing "maintenance doses" lower than the labeled max
The honest answer: microdosing is an off-label, user-driven trend. Anecdotal reports are promising, but you're essentially running an experiment on yourself. That's why tracking matters — you need data to know if your protocol is actually holding.
What to track if you're microdosing
The trap with microdosing is that weight regain happens slowly. You might feel fine for two months, then notice the scale creeping up. Tracking gives you an early warning.
Worth logging:
- Weekly weight (same day, same time, same conditions)
- Dose and date of each injection
- Hunger and cravings on a 1-10 scale, ideally daily
- Side effects if any return
- Waist measurement monthly — sometimes weight stays flat while body composition shifts
Trace is built for exactly this kind of tracking. You log doses, symptoms, and weight in one place, all stored locally on your device with Face ID protection. No cloud syncing, no data shared with anyone. For maintenance protocols where you're watching trends over months, having a clean private log makes it much easier to spot when something stops working.
Frequently Asked Questions
What's the smallest effective dose of semaglutide?
There's no established minimum, but many users report appetite suppression at 0.25 mg weekly — the lowest titration step. Some go lower by splitting doses. Effectiveness varies by individual, so tracking your hunger response matters more than chasing a specific number.
Can I microdose tirzepatide?
Yes, people do it, often using 2.5 mg every 1-2 weeks for maintenance. Tirzepatide has a longer half-life than semaglutide, which makes spaced-out dosing feasible. As always, talk to your doctor before changing protocols.
Will I regain weight if I microdose instead of staying on full dose?
Possibly. Studies show weight regain when GLP-1s are stopped entirely, but microdosing is less studied. The honest answer is it depends on your metabolism, lifestyle, and how much weight you lost. Track closely so you catch any regain early.